Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 54 EUR -1.1% Market Closed
Market Cap: 522.7m EUR
Have any thoughts about
Pharmanutra SpA?
Write Note
Section:
 

Relative Value

The Relative Value of one PHN stock under the Base Case scenario is 44.99 EUR. Compared to the current market price of 54 EUR, Pharmanutra SpA is Overvalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHN Relative Value
Base Case
44.99 EUR
Overvaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
92
vs Industry
15
Median 3Y
5.1
Median 5Y
4.5
Industry
1
Forward
4.5
More Details
24.2
P/E
P/E
Price to Earnings
24.2
vs History
57
vs Industry
20
Median 3Y
27.3
Median 5Y
25.1
Industry
16.8
Forward
29.6
More Details
22.7
P/OCF
P/OCF
Price to OCF
22.7
vs History
76
vs Industry
8
Median 3Y
39
Median 5Y
31.3
Industry
11.9
More Details
31.4
P/FCFE
P/FCFE
Price to FCFE
31.4
vs History
61
vs Industry
12
Median 3Y
33.1
Median 5Y
33.6
Industry
17.6
More Details
9.5
P/B
P/B
Price to Book Value
9.5
vs History
52
vs Industry
5
Median 3Y
11
Median 5Y
9.6
Industry
1.6
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
92
vs Industry
15
Median 3Y
4.9
Median 5Y
4.4
Industry
1.2
Forward
4.5
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
92
vs Industry
48
Median 3Y
5.1
Median 5Y
4.5
Industry
3.8
More Details
12.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.9
vs History
84
vs Industry
25
Median 3Y
17
Median 5Y
15.8
Industry
10.3
Forward
16
More Details
14.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.7
vs History
76
vs Industry
27
Median 3Y
17.8
Median 5Y
17.5
Industry
12.9
Forward
18.6
More Details
22.7
EV/OCF
EV/OCF
Enterprise Value to OCF
22.7
vs History
69
vs Industry
8
Median 3Y
38.4
Median 5Y
29.9
Industry
12.1
More Details
26.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.8
vs History
63
vs Industry
1
Median 3Y
30.4
Median 5Y
28.9
Industry
15.3
More Details
6.6
EV/IC
EV/IC
Enterprise Value to IC
6.6
vs History
69
vs Industry
10
Median 3Y
8
Median 5Y
9.2
Industry
1.2
More Details

Multiples Across Competitors

PHN Competitors Multiples
Pharmanutra SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Pharmanutra SpA
MIL:PHN
518.8m EUR 3.3 24.2 12.9 14.7
JP
Fancl Corp
TSE:4921
336.7B JPY 3.1 47.6 19.9 26.9
FR
L'Oreal SA
PAR:OR
181.7B EUR 4.3 28 18.7 22.2
UK
Unilever PLC
LSE:ULVR
114.1B GBP 2.3 20.7 177.4 204
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 53.1 36.5 39.8
UK
HALEON PLC
LSE:HLN
34.9B GBP 3.1 28.9 17.2 19.7
DE
Beiersdorf AG
XETRA:BEI
27.8B EUR 2.9 37.6 16 22.9
US
Estee Lauder Companies Inc
NYSE:EL
26.5B USD 1.7 131.5 12.9 19.6
JP
Kao Corp
TSE:4452
3T JPY 1.9 36.2 14.4 25.9
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.9 -297.8 35.4 37.8
IN
Dabur India Ltd
NSE:DABUR
903.7B INR 7.3 50.5 38.3 46.7
P/E Multiple
Earnings Growth P/E to Growth
IT
Pharmanutra SpA
MIL:PHN
Average P/E: 45.8
24.2
95%
0.3
JP
F
Fancl Corp
TSE:4921
47.6
50%
1
FR
L'Oreal SA
PAR:OR
28
30%
0.9
UK
Unilever PLC
LSE:ULVR
20.7
25%
0.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
53.1
32%
1.6
UK
HALEON PLC
LSE:HLN
28.9
-7%
N/A
DE
Beiersdorf AG
XETRA:BEI
37.6
61%
0.6
US
Estee Lauder Companies Inc
NYSE:EL
131.5
245%
0.5
JP
Kao Corp
TSE:4452
36.2
205%
0.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -297.8 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
50.5
39%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IT
Pharmanutra SpA
MIL:PHN
Average EV/EBITDA: 36.3
12.9
57%
0.2
JP
F
Fancl Corp
TSE:4921
19.9
37%
0.5
FR
L'Oreal SA
PAR:OR
18.7
28%
0.7
UK
Unilever PLC
LSE:ULVR
177.4
20%
8.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.5
29%
1.2
UK
HALEON PLC
LSE:HLN
17.2
13%
1.3
DE
Beiersdorf AG
XETRA:BEI
16
11%
1.4
US
Estee Lauder Companies Inc
NYSE:EL
12.9
26%
0.5
JP
Kao Corp
TSE:4452
14.4
55%
0.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
35.4
41%
0.9
IN
Dabur India Ltd
NSE:DABUR
38.3
35%
1.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IT
Pharmanutra SpA
MIL:PHN
Average EV/EBIT: 43.7
14.7
58%
0.3
JP
F
Fancl Corp
TSE:4921
26.9
N/A N/A
FR
L'Oreal SA
PAR:OR
22.2
34%
0.7
UK
Unilever PLC
LSE:ULVR
204
22%
9.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.8
31%
1.3
UK
HALEON PLC
LSE:HLN
19.7
13%
1.5
DE
Beiersdorf AG
XETRA:BEI
22.9
21%
1.1
US
Estee Lauder Companies Inc
NYSE:EL
19.6
35%
0.6
JP
Kao Corp
TSE:4452
25.9
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
37.8
44%
0.9
IN
Dabur India Ltd
NSE:DABUR
46.7
37%
1.3

See Also

Summary
PHN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHN stock valuation using valuation multiples.
Wall Street Estimates
PHN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.